Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis.
Ranganathan, D; Leibowitz, S; John, GT; Neller, MA; Ambalathingal, GR; Beagley, L; Panikkar, A; Best, S; Raju, J; Reddiex, H; Ratanjee, S; Ng, MSY; Smith, C; Khanna, R
Clinical & translational immunology - 19/12/2024
Patient Reported Outcome Measures in cancer care: a hybrid effectiveness-Implementation trial to optimise Symptom control and health service Experience (PROMISE)-protocol for a randomised controlled trial of electronic self-reporting of symptoms versus usual care during and following treatment in patients with cancer.
Webb, PM; Brown, A; Brown, B; Collins, LG; Crawford Williams, F; Doupain, K; Eastgate, M; Fennelly, V; Girgis, A; Hartel, G; Ladwa, R; Martin, K; Mason, R; McGuire, P; Miller, E; O'Brien, S; Packer, R; Pinkham, MB; Sabesan, S; Sanmugarajah, J; Slapp, G; Tapsall, D; White, J; Wishart, LR; Wyld, D; Chan, RJ
BMJ Open - 19/12/2024